Innate Pharma (ADR) - IPHA - stock price prediction, stock price target, analyst ratings from 5 analysts

Innate Pharma (ADR) has a share price target of US$ 5, revenue growth forecast of -19.5%, and profit growth estimate of -12.7% for FY25, based on top 5 analyst calls.